• 
• 
• english
• français
• русский

Archivo: Grupo de Investigación

 

2001 Session of the Research Group of the Standing Technical Committee of EuFMD
Island of Moen, Denmark 12-15 September 2001

 

Informe Completo (en inglés)
Apéndices
Introduction
1. FMD situation in Europe and over the world in 2001
2. The situation of FMD in Turkey
3. Molecular epidemiology of foot-and-mouth disease virus: The current situation in Europe and the Middle East
4. Sequence data of the foot-and-mouth disease outbreaks in the Netherlands; how do they correspond with the results from tracing
5. Report on the outbreak in France
6. The epidemic of foot-and-mouth disease in the Netherlands in 2001: laboratory examinations
7. Pirbright's role in the UK 2001 FMD epidemic and its response to the emergency
8. Report on the production of emergency O1 Manisa foot-and-mouth disease vaccine for the UK by the International Vaccine Bank (IVB), 22 March - 4 April 2001
9. Appendix 9 - The Spanish diagnosis experience during the 2001 FMD European crisis
10. Surveillance of FMD in Italy during 2001
11. Preventive measures and disease vigilance in Denmark following the current outbreak of FMD in the UK
12. Preventive measures and laboratory examinations in Germany following the current outbreaks of FMD in the EU
13. The FMD crisis 2001: field measures, laboratory tests and procedure for mass screening in Belgium
14. The 2001 FMD outbreak in the EU: an unforeseen interest for the diseasein Switzerland
15. Validation of the FAO Type O reference sera using sera collected on outbreak farms
16. Intervet: Presentation of ELISA kit developed with Brescia and Pirbright
17. Bayer: Results achieved so far with the test for antibodies against NSP's of FMDV
18. Merial: Presentation of datas
19. Biomedical: Presentation of ELISA tests on NSP
20. Experience of IAEA
21. The results of the serological surveillance following the vaccination in Thrace region in 2000
22. The results of the 3ABC ELISA serosurvey conducted with the sera obtained from Thrace
23. SReport on the Workshop held in Lelystad on 28 and 29 June 2001
24. Carrier sheep discovered during the Dutch foot-and-mouth disease Epidemic: A case report
25. Evaluation of automated RT-PCR systems to accelerate FMD diagnosis
26. A novel method for detection of FMDV from culture and clinical samples by RT-PCR and Restriction Enzyme Analysis
27. Validation of a LightCycler based RT-PCR for the detection of foot-and-mouth disease
28. Validation of a monoclonal antibody-based ELISA for multi-species detection of antibodies in serum directed against Type O foot-and-mouth disease virus
29. Quantities of infectious virus and viral RNA recovered from sheep and cattle experimentally infected with foot-and-mouth disease virus O UK 2001
30. Further studies to quantify the dose of natural aerosols of foot-and-mouth disease virus for pigs
31. Risk assessment regarding transit quarantine of exotic ruminants originating from countries harbouring foot-and-mouth disease
32(a). The studies on the possible new Type 'O' FMDV variant in Turkey 32(b). FMD virus strains circulating in Turkey
33. Activities regarding the improvement of the FMD vaccine's quality
34. Stratified and cryogenically stored SACs vaccines, a novel formulating procedure for extending the shelf-life of emergency foot-and-mouth disease vaccines
35. Provisional recommendations from the World Reference Laboratory on FMD Virus strains to be included in FMDV antigen banks (Unavailable)
36. Report on the meetings and discussions with Eur. Pharm. and EMEA
37. TReport on the Joint EuFMD/EC Workshop on foot-and-mouth disease simulation exercises held in Brno, 5-7 June 2001
38. Information on the new Italian Reference Laboratory for vesicular diseases (CERVES)
39. List of Participants